VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
FTREFortrea Holdings Inc.
$15.56$1.5B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksFTREP/E History

FTRE logoFortrea Holdings Inc. (FTRE) P/E Ratio History

Deep Value

Trading at -1.4x · 0th percentile of 5-year range · Significant discount to historical valuation · Data 2023–2023

Current P/E (TTM)
-1.4x
-102% vs 5Y avg
5Y Avg P/E
84.1x
Median 84.1x
5Y Percentile
0th
Lower end of range
PEG Ratio
N/A
TTM EPS$-4.90
Price$15.56
Earnings YieldN/A
EPS Growth (1Y)-194.6%
EPS Growth (5Y)N/A

Loading P/E history...

P/E Ratio Analysis

As of June 22, 2026, Fortrea Holdings Inc. (FTRE) trades at a price-to-earnings ratio of -1.4x, with a stock price of $15.56 and trailing twelve-month earnings per share of $-4.90.

The current P/E is 102% below its 5-year average of 84.1x. Over the past five years, FTRE's P/E has ranged from a low of 84.1x to a high of 84.1x, placing the current valuation at the 0th percentile of its historical range.

Compared to the Healthcare sector median P/E of 22.1x, FTRE trades at a 107% discount to its sector peers. The sector includes 233 companies with P/E ratios ranging from 0.0x to 194.5x.

Relative to the broader market, FTRE trades at a notable discount to the S&P 500 median P/E of 24.3x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.

For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our FTRE DCF Valuation Calculator →

Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.

FTRE Cross-Benchmark Valuation

How does the current P/E compare to sector peers and the broader market?

vs. Healthcare
-1.4vs22.1
-107%
Below Sector
vs. S&P 500
-1.4vs24.3
-106%
Below Market
PEG Analysis
N/A
P/E ÷ EPS Growth
Based on -195% EPS growth (1Y)

FTRE P/E vs Peers

Biopharma Services and CROs peers sorted by market cap

CompanyMarket CapP/E RatioPEG RatioEPS Growth (1Y)
IQV logoIQVIQVIA Holdings Inc.
$28B21.4Lowest0.53Best+5%
MEDP logoMEDPMedpace Holdings, Inc.
$13B29.80.95+21%Best
PRA logoPRAProAssurance Corporation
$1B24.8--4%
ICLR logoICLRICON Public Limited Company
$11B48.5--70%
LH logoLHLabcorp Holdings Inc.
$21B24.3-+18%
DGX logoDGXQuest Diagnostics Incorporated
$21B22.1-+14%
HIMS logoHIMSHims & Hers Health, Inc.
$7B65.8--4%
TMO logoTMOThermo Fisher Scientific Inc.
$172B26.212.40+7%

Lower P/E can signal a discount or weaker growth expectations; PEG adds growth context.

FTRE Historical P/E Data (2023–2023)

Quarterly P/E ratios calculated from closing price and TTM EPS

QuarterPeriod EndPriceTTM EPSP/E Ratiovs Avg
FY2023 Q3Sep 30 2023$28.59$0.3484.1x+0%

Average P/E for displayed period: 84.1x

Export Data
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

3+ years return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

FTRE — Frequently Asked Questions

Quick answers to the most common questions about buying FTRE stock.

What is FTRE's P/E ratio?

Fortrea Holdings Inc. (FTRE) trailing twelve-month P/E ratio is -1.4x, based on TTM diluted EPS of $-4.90. The 5-year average P/E is 84.1x and the historical range spans 84.1x to 84.1x.

Is FTRE stock overvalued or undervalued?

FTRE trades at -1.4x P/E, below its 5-year average of 84.1x. At the 0th percentile of its historical range (84.1x–84.1x), the stock is priced at a discount to its own history.

Is FTRE stock expensive?

No, FTRE is not expensive on a historical basis. The current P/E of -1.4x is below the 5-year average of 84.1x and sits at the 0th percentile of its valuation range.

What is FTRE's historical P/E range?

Over the past 5 years, FTRE's P/E ratio has ranged from 84.1x to 84.1x, with a median of 84.1x and an average of 84.1x. The current P/E of -1.4x places the stock at the 0th percentile of this range. Full historical data spans 2023–2023.

How does FTRE's P/E compare to the S&P 500?

FTRE trades at -1.4x P/E versus the S&P 500 median of 24.3x. The 106% discount to the market suggests lower growth expectations or perceived higher risk.

How does FTRE's valuation compare to Healthcare peers?

Fortrea Holdings Inc. P/E of -1.4x compares to the Healthcare sector median of 22.1x. The discount suggests lower growth expectations, weaker margins, or higher perceived risk relative to peers. See the peer comparison table on this page for ticker-by-ticker P/E and PEG.

What is FTRE's PEG ratio?

FTRE PEG ratio is N/A, based on a P/E of -1.4x and EPS growth of -194.6%. PEG normalises P/E by growth and helps compare stocks with different earnings trajectories.

What is FTRE's earnings yield?

FTRE earnings yield is N/A, the inverse of its -1.4x P/E ratio. Earnings yield represents the percentage of each dollar invested that the company earns. It can be compared directly to bond yields to assess relative attractiveness of stocks versus fixed income.

FTRE P/E Ratio History (2023–2023)

Quarterly valuation multiple from closing price and trailing EPS

Current84.1x
Period Avg84.1x
Range84.1x - 84.1x
Change+0%
1 quartersSep 30, 2023 - Sep 30, 2023